2019
Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease
Landau SI, Guo X, Velazquez H, Torres R, Olson E, Garcia-Milian R, Moeckel GW, Desir GV, Safirstein R. Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease. Kidney International 2019, 95: 797-814. PMID: 30904067, PMCID: PMC6543531, DOI: 10.1016/j.kint.2018.11.042.Peer-Reviewed Original ResearchConceptsChronic kidney diseaseKidney diseaseKidney injuryCisplatin-induced chronic kidney diseaseCisplatin-induced acute kidney injuryToll-like receptor 2Regulated necrosis pathwaysReversible kidney injuryAcute kidney injuryChronic kidney injuryProximal tubular damageKidney injury markersDoses of cisplatinEvidence of fibrosisMechanisms of progressionEffective chemotherapeutic agentWestern blot analysisFirst doseInjury markersIntraperitoneal cisplatinSignificant nephrotoxicityTubular damageKidney functionSecond doseCisplatin administration
2015
Serum Renalase Levels Correlate with Disease Activity in Lupus Nephritis
Qi C, Wang L, Zhang M, Shao X, Chang X, Fan Z, Cao Q, Mou S, Wang Q, Yan Y, Desir G, Ni Z. Serum Renalase Levels Correlate with Disease Activity in Lupus Nephritis. PLOS ONE 2015, 10: e0139627. PMID: 26431044, PMCID: PMC4592194, DOI: 10.1371/journal.pone.0139627.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkersCase-Control StudiesCross-Sectional StudiesDisease ProgressionFemaleHumansLupus NephritisMaleMiddle AgedMonoamine OxidaseConceptsSerum renalase levelsActive lupus nephritisLupus nephritisDisease activityProliferative lupus nephritisRenalase levelsLN patientsSystemic lupus erythematosusStandard therapyDisease progressionHealthy controlsActive LN patientsInactive lupus nephritisProliferative LN patientsSLEDAI-2KSLE disease activityUrine protein excretionKidneys of patientsCross-sectional studyExpression of renalaseCytokine-like proteinLupus erythematosusSerious complicationsProtein excretionSerum renalase